Why the study?
Direct electrophysiological methods are labor-intensive and automated patch clamp systems are cost-prohibitive, making fluorescence-based assays important for initial high-throughput screening of ion channel modulators.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
May accelerate early ion channel drug discovery; leaves open clinical translation of identified hits.
Ion channels represent a druggable family of transmembrane pore-forming proteins with important (patho)physiological functions. While electrophysiological measurement (manual patch clamp) remains the only direct method for detection of ion currents, it is a labor-intensive technique. Although automated patch clamp instruments have become available to date, their high costs limit their use to large pharma companies or commercial screening facilities. Therefore, fluorescence-based assays are particularly important for initial screening of compound libraries. Despite their numerous disadvantages, they are highly amenable to high-throughput screening and in many cases, no sophisticated instrumentation or materials are required. These features predispose them for implementation in early phases of drug discovery pipelines (hit identification), even in an academic environment. This review summarizes the advantages and pitfalls of individual methodological approaches for identification of ion channel modulators employing fluorescent probes (i. e., membrane potential and ion flux assays) with emphasis on practical aspects of their adaptation to high-throughput format.
No takes yet. Share an insight, caveat, or question.
Voldřich et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: